Table 3 Top ten genera by prevalence stratified by clinical state

From: Microbiome networks and change-point analysis reveal key community changes associated with cystic fibrosis pulmonary exacerbations

 

Rank

Genus

Mean (%)

Median (%)

Stdev

Prev. (%)

RA rank

Hub rank

Metab.a

Baseline

1

Prevotella

12.537

6.257

15.089

100.0

2

4

2

Rothia

6.383

2.002

13.623

100.0

4

54

3

Streptococcus

9.705

5.769

11.204

98.8

3

10

+

4

Actinomyces

2.419

0.666

4.089

98.8

8

19

5

Veillonella

3.455

1.460

4.994

95.0

6

2

6

Gemella

1.528

0.393

2.769

95.0

11

11

+/−

7

Pseudomonas

41.289

46.880

36.709

92.5

1

5

+

8

Stenotrophomonas

6.289

0.023

20.681

92.5

5

23

+

9

Staphylococcus

1.076

0.011

4.598

90.0

14

41

+/−

10

Solobacterium

0.485

0.041

1.034

85.0

18

25

Unwell

1

Streptococcus

12.074

5.016

14.122

98.8

3

25

+

2

Rothia

5.884

1.776

12.203

98.2

5

14

3

Prevotella

15.143

6.885

19.744

96.5

2

16

4

Veillonella

4.898

0.886

8.430

93.6

6

11

5

Actinomyces

2.138

0.217

4.041

93.0

9

19

6

Stenotrophomonas

9.389

0.096

18.196

87.7

4

9

+

7

Pseudomonas

30.790

13.553

34.454

84.2

1

6

+

8

Staphylococcus

2.631

0.015

9.910

81.3

8

99

+/−

9

Gemella

1.306

0.020

3.857

81.3

13

12

+/−

10

Solobacterium

0.499

0.035

1.812

72.5

16

4

PE

1

Streptococcus

14.127

9.869

13.198

100.0

2

22

+

2

Prevotella

9.927

7.086

12.885

100.0

3

9

3

Rothia

6.466

0.480

15.744

100.0

4

35

4

Haemophilus

4.755

0.023

17.451

100.0

6

52

+/−

5

Veillonella

2.894

1.069

3.511

100.0

8

11

6

Actinomyces

2.311

0.517

3.661

100.0

9

1

7

Staphylococcus

0.474

0.099

0.984

100.0

17

36

+/−

8

Neisseria

0.228

0.014

0.488

100.0

26

23

+

9

Pseudomonas

36.645

33.068

36.134

93.8

1

30

+

10

Stenotrophomonas

2.275

0.092

5.406

93.8

10

29

+

  1. Prev. prevalence, RA relative abundance
  2. aMetab. = Metabolism: + aerobic, − anaerobic, +/− facultative anaerobic